PAX8 and thyroid gland papillary carcinoma: Recently, we have demonstrated that TAZ acts as a potent regulator of Pax8 and TTF-1 activity [9] and we have also reported that TAZ, already known to promote cell proliferation and to induce epithelial–mesenchymal transition [30], is overexpressed in papillary thyroid cancer [31].